Addition of long-acting beta2 -agonists to inhaled corticosteroids for chronic asthma in children-Reference-Cited by-同舟云学术

Addition of long-acting beta2 -agonists to inhaled corticosteroids for chronic asthma in children

Published:2015-11-24 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Chauhan Bhupendrasinh F¹²³,Chartrand Caroline⁴,Ni Chroinin Muireann⁵,Milan Stephen J⁶,Ducharme Francine M⁷⁸

Affiliation:

1. University of Manitoba; Faculty of Pharmacy; Winnipeg MB Canada

2. University of Manitoba; Knowledge Synthesis, George and Fay Yee Centre for Healthcare Innovation; Winnipeg Regional Health Authority Winnipeg MB Canada

3. Sainte-Justine University Hospital Research Center, University of Montreal; Department of Paediatrics; Montreal Canada

4. CHU Sainte-Justine Hospital; Department of Pediatrics; Montreal QC Canada

5. Cork University Hospital; Division of Children's Services; Cork Ireland

6. Lancaster University; Lancaster Health Hub; Lancaster UK

7. University of Montreal; Department of Paediatrics; Montreal QC Canada

8. CHU Sainte-Justine; Research Centre; Montreal Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference199 articles.

1. Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial;Akpinarli;Archives of Disease in Childhood,1999

2. AstraZeneca Pharmaceuticals (SD 039 0719) A six-month, randomized, open-label safety study of Symbicort® (160/4.5 mcg) compared to Pulmicort Turbuhaler® in asthmatic children aged 6 to 11 years http://www.astrazenecaclinicaltrials.com (accessed 4 January 2008)

3. The safety and clinical benefit of budesonide/formoterol pressurized metered-dose inhaler versus budesonide alone in children;Berger;Allergy Asthma Proceedings,2010

4. Oxis and Pulmicort turbuhaler in the management of asthma OPTIMA international study group. Treatment of mild persistent asthma with low doses of inhaled budesonide alone or in combination with formoterol;Barnes;Thorax,2000

5. Barnes PJ O'Byrne PM Rodriguez-Roisin R Runnerstrom E Sandstrom T Svensson K Treatment of mild persistent asthma with low doses of inhaled budesonide alone or in combination with formoterol. For the Oxis and Pulmicort Turbuhaler in the Management of Asthma (OPTIMA) international study group Thorax 2000 s5

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evidence gap map of interventions for noncommunicable diseases and risk factors among children and adolescents;Nature Medicine;2024-01

2. Doxofylline as a steroid-sparing treatment in Mexican children with asthma;Journal of Asthma;2023-12-28

3. Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years;Monaldi Archives for Chest Disease;2023-09-07

4. Efficacy, Safety, and Systemic Exposure of Once-Daily Indacaterol Acetate in Pediatric Asthma: A Randomized, Double-Blind, Controlled Dose-Finding Study;Clinical Drug Investigation;2023-09

5. General Anesthesia in Early Childhood Significantly Reduces Asthma Incidence and Clinical Visits: A Nationwide Population-Based Cohort Study;Children;2023-03-27